A pilot evaluation of the use of tissue microarrays for quantitation of target distribution in drug discovery

Jennifer S McKay1, Alison Bigley, Alex Bell

  • 1Department of Pathology, Safety Assessment, AstraZeneca, Alderley Park, Cheshire SK10 4TG, UK. jenny.mckay@astrazeneca.com

Insights

This study validates the Chromavision automated cellular imaging system (ACIS) for quantifying mRNA and protein distribution in tissue microarrays (TMAs). The ACIS provides powerful quantitative data for target distribution evaluation in discovery pathology.

Area of Science:

  • Pathology
  • Molecular Biology
  • Biotechnology

Background:

  • Tissue microarrays (TMAs) are increasingly used for novel target molecule distribution studies in organs.
  • Automated cellular imaging systems offer potential for efficient quantitation of molecular targets.

Purpose of the Study:

  • To assess the Chromavision automated cellular imaging system (ACIS) for quantitating mRNA and protein distribution in rat and dog TMAs.
  • To develop and evaluate a method for target distribution analysis using ACIS in conjunction with pathologist review.

Main Methods:

  • Utilized TMAs from rat and dog tissues.
  • Assessed messenger RNA (mRNA) distribution of P-CIP2 using oligonucleotide probes and protein distribution of peptidylglycine amidating monoxygenase (PAM) via immunohistochemistry (IHC).
  • Employed a two-tier ACIS analysis: initial scanning for target expression and detailed analysis of selected regions of interest.

Main Results:

  • The ACIS successfully provided quantitative data on P-CIP2 and PAM distribution in different cellular populations within tissue cores.
  • A comparative semi-quantitative analysis by a pathologist validated the ACIS findings.
  • The developed methodology demonstrated the system's power for in situ hybridization and IHC analysis on normal TMAs.

Conclusions:

  • The ACIS is a powerful tool for quantitative analysis of target distribution in discovery pathology.
  • The combination of ACIS imaging analysis and pathologist histological review provides a robust guideline for future target distribution evaluations.

Related Concept Videos